Neuronetics (STU:NRC) Notes Receivable : €0.64 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Neuronetics Notes Receivable?

Neuronetics's Notes Receivable for the quarter that ended in Mar. 2025 was €0.64 Mil.

Neuronetics's quarterly Notes Receivable declined from Sep. 2024 (€2.23 Mil) to Dec. 2024 (€0.89 Mil) but then stayed the same from Dec. 2024 (€0.89 Mil) to Mar. 2025 (€0.64 Mil).

Neuronetics's annual Notes Receivable increased from Dec. 2022 (€0.22 Mil) to Dec. 2023 (€1.89 Mil) but then declined from Dec. 2023 (€1.89 Mil) to Dec. 2024 (€0.89 Mil).

Neuronetics Notes Receivable Historical Data

The historical data trend for Neuronetics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuronetics Notes Receivable Chart

Neuronetics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Notes Receivable

Get a 7-Day Free Trial

0.07

0.22

1.89

0.89

Neuronetics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Notes Receivable	Get a 7-Day Free Trial															1.95	2.20	2.23	0.89	0.64

Neuronetics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Neuronetics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Neuronetics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuronetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neuronetics Inc (STU:NRC) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

STIM:USA

Address

3222 Phoenixville Pike, Malvern, PA, USA, 19355

Website

https://www.neurostar.com

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.